title: [Post-transfusional hepatitis B: a solvable problem? (author's transl)].
abstract: Forty-four patients with haemophilia A or von Willebrand-Jürgens syndrome were followed for three years. They received about 28 000 cryoprecipitate produced in the author's laboratories, without a single case of hepatitis B. There were seven among these patients who had no antibodies against surface antigen: they had received a total of 2533 cryoprecipitate. There were no seroconversion or transaminase changes in comparison with values before cryoprecipitates.
mesh_terms: D000368:Aged; D005169:Factor VIII / Q000627:therapeutic use; D006467:Hemophilia A / Q000188:drug therapy; D006509:Hepatitis B / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000032:analysis; D006514:Hepatitis B Surface Antigens; D006801:Humans; D008297:Male; D014842:von Willebrand Diseases / Q000628:therapy
chemical_list: D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D005169:Factor VIII
vernacular_title: Posttransfusionelle Hepatitis B: ein heute lösbares Problem? Am Beispiel der Hämophilie.